117 related articles for article (PubMed ID: 27278115)
1. Expression of VEGFR and PDGFR-α/-β in 187 canine nasal carcinomas.
Gramer I; Killick D; Scase T; Chandry D; Marrington M; Blackwood L
Vet Comp Oncol; 2017 Sep; 15(3):1041-1050. PubMed ID: 27278115
[TBL] [Abstract][Full Text] [Related]
2. Receptor tyrosine kinase expression and phosphorylation in canine nasal carcinoma.
Hocker SE; Higginbotham ML; Schermerhorn T; Henningson J
Res Vet Sci; 2017 Dec; 115():484-489. PubMed ID: 28783596
[TBL] [Abstract][Full Text] [Related]
3. PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.
Gattino F; Maniscalco L; Iussich S; Biasato I; Martano M; Morello E; Gola C; Millán Ruiz Y; Saeki N; Buracco P; Martín de Las Mulas J; De Maria R
Vet Rec; 2018 Aug; 183(7):221. PubMed ID: 29440590
[TBL] [Abstract][Full Text] [Related]
4. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro.
Milovancev M; Helfand SC; Marley K; Goodall CP; Löhr CV; Bracha S
BMC Vet Res; 2016 Jun; 12():85. PubMed ID: 27259510
[TBL] [Abstract][Full Text] [Related]
6. Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.
Yonemori K; Tsuta K; Ando M; Hirakawa A; Hatanaka Y; Matsuno Y; Chuman H; Yamazaki N; Fujiwara Y; Hasegawa T
Ann Surg Oncol; 2011 Oct; 18(10):2841-50. PubMed ID: 21409488
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-β, and CDK4 in canine urothelial carcinoma.
Setyo LC; Donahoe SL; Shearer PL; Wang P; Krockenberger MB
J Vet Diagn Invest; 2023 Mar; 35(2):109-115. PubMed ID: 36648148
[TBL] [Abstract][Full Text] [Related]
8. Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
Hofer MD; Fecko A; Shen R; Setlur SR; Pienta KG; Tomlins SA; Chinnaiyan AM; Rubin MA
Neoplasia; 2004; 6(5):503-12. PubMed ID: 15548358
[TBL] [Abstract][Full Text] [Related]
9. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
Walters L; Martin O; Price J; Sula MM
Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928
[TBL] [Abstract][Full Text] [Related]
10. Expression of platelet-derived growth factor receptor-α/ß, vascular endothelial growth factor receptor-2, c-Abl, and c-Kit in canine granulomatous meningoencephalitis and necrotizing encephalitis.
Song JH; Yu DH; Hwang TS; Seung BJ; Sur JH; Kim YJ; Jung DI
Vet Med Sci; 2020 Nov; 6(4):965-974. PubMed ID: 32585777
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Biomarkers Between Hepatic Tumors in Rat Models and a Dog.
Kim S; Kim Y; Kim SE; Kim HJ
In Vivo; 2023; 37(1):252-261. PubMed ID: 36593028
[TBL] [Abstract][Full Text] [Related]
12. Analysis of genomic mutation and immunohistochemistry of platelet-derived growth factor receptors in canine vascular tumours.
Abou Asa S; Mori T; Maruo K; Khater A; El-Sawak A; Abd el-Aziz E; Yanai T; Sakai H
Vet Comp Oncol; 2015 Sep; 13(3):237-45. PubMed ID: 23611531
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of ponatinib in vitro effect in three canine mast cell tumor cell lines expressing FGFR-1, PDGFR-α, and VEGFR-2.
Fisher CJ; Lejeune AT; Dark MJ; Hernandez OM; Shiomitsu K
Vet J; 2021 Mar; 269():105621. PubMed ID: 33593493
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factors and receptors in Canine Lymphoma.
Aricò A; Guadagnin E; Ferraresso S; Gelain ME; Iussich S; Rütgen BC; Mazzariol S; Marconato L; Aresu L
J Comp Pathol; 2014 Nov; 151(4):322-8. PubMed ID: 25172054
[TBL] [Abstract][Full Text] [Related]
15. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression.
Carvalho I; Milanezi F; Martins A; Reis RM; Schmitt F
Breast Cancer Res; 2005; 7(5):R788-95. PubMed ID: 16168125
[TBL] [Abstract][Full Text] [Related]
17. PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis.
Iussich S; Maniscalco L; Di Sciuva A; Iotti B; Morello E; Martano M; Gattino F; Buracco P; De Maria R
Vet Comp Oncol; 2017 Jun; 15(2):462-469. PubMed ID: 26833575
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the therapeutic potential of masitinib and expression of its specific targets c-Kit, PDGFR-α, PDGFR-β, and Lyn in canine prostate cancer cell lines.
Klose K; Packeiser EM; Granados-Soler JL; Hewicker-Trautwein M; Murua Escobar H; Nolte I
Vet Comp Oncol; 2022 Sep; 20(3):641-652. PubMed ID: 35384248
[TBL] [Abstract][Full Text] [Related]
19. Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.
Patel SH; Kneuertz PJ; Delgado M; Kooby DA; Staley CA; El-Rayes BF; Kauh JS; Sarmiento JM; Hanish S; Cohen C; Farris AB; Maithel SK
Ann Surg Oncol; 2011 Nov; 18(12):3384-90. PubMed ID: 21590454
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
